IFIH1 and dermatomyositis: Therefore, the current study sought to develop a pre-therapeutic prediction tool based on baseline clinical and laboratory indicators to predict mortality risk in Asian patients with anti-MDA5 DM-ILD and guide clinical decision-making early.